Xeriant, Inc.
XERI· OTC
XERIXeriant, Inc.
Filed Feb 16, 2023 · 10-Q · 47 days after period end · 0001477932-23-001086
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Net Income | -$1.29M | -$5.53M | -$1.19M | -$277.03K |
| EPS Diluted | — | -$0.02 | -$0.01 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xeriant, Inc. · CIK 1481504 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Feb 16, 2023 · 47 d after period end
